Medtronic acquires Heartware International

Medtronic to Expand Heart Failure Portfolio with Acquisition of Heartware International Medtronic plc Extends Clinical and Commercial Leadership Into Growing Circulatory Support Sector DUBLIN and FRAMINGHAM, Mass. – June 27, 2016 – Medtronic plc (NYSE: MDT), the global leader in medical technology, and HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less-invasive, miniaturized circulatory Continue Reading

From Medtronic Micra Transcatheter Pacemaker System

This is a brief overview of information related to FDA’s approval to market this product. See the links below to the Summary of Safety and Effectiveness Data (SSED) and product labeling for more complete information on this product, its indications for use, and the basis for FDA’s approval.

Latest updates on TMVI

CardiAQ™ Valve Technologies Reports First-in-Human Percutaneous Transfemoral, Transseptal Implantation with Its Second Generation Transcatheter Bioprosthetic Mitral Heart Valve Nearly 50% of patients suffering from a diseased mitral heart valve with severe, symptomatic regurgitation are currently denied open-heart surgery because it is considered too risky; in the future, percutaneous Transcatheter Mitral Valve Implantation (TMVI) may offer Continue Reading

Incoming a pacemaker without batteries – Health

Incoming a pacemaker without batteries It is powered with heart beat, it will allow to avoid surgical interventions to substitute batteries to improve patients comfort reducing risks Heart risks also among joung people 16:21 – An innovative pacemaker able to operate without batteries, supplied with the beat of the heart. A step forward in hi-tech Continue Reading

PHARMASTAR :: new confirmation for bio-absorbable stents

07 June 2012 Bioabsorbable polymer and drug eluting stents can reduce the risk of thrombosis intrastent to 4 years in patients undergoing coronary angioplasty primary. These results come from an analysis recently published on European Heart Journal. Data of individual patients from three randomised clinical trials, multicenter and large-scale (ISAR-TEST 3, ISAR-TEST 4, and LEADERS), Continue Reading

Announced development of fully implantable ventricular assist system.

HeartWare and Dualis MedTech Announce Agreement to Develop Fully Implantable Ventricular Assist System FRAMINGHAM, Mass. and SYDNEY, Jan. 9, 2012 /PRNewswire/ — HeartWare International, Inc. (NASDAQ: HTWR – ASX: HIN), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, and Dualis MedTech GmbH, a subsidiary Continue Reading


They are small tubes inserted into coronary arteries during transcutaneous angioplasty intervention  and some of them are able to elute drugs into vessel lumen wall to prevent restenosis. Coronary angioplasty has revolutionised the treatment of coronary atherosclerotic disease since its appearance in the mid 70. The introduction of coronary stenting has represented an important step Continue Reading